Individuals Coming Off Anti-Obesity Medications Regain Pounds Four Times Faster Than People Using Diet and Exercise

New research indicates that individuals who stop using new weight-loss injections like Wegovy and Mounjaro can put back on lost weight far faster than those who halt traditional lifestyle regimens.

Research printed in a leading health publication shows that while overweight people frequently drop substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"People purchasing these treatments should be informed of the danger of rapid weight regain when the treatment is stopped," stated expert Dr. Susan Jebb.

That rate of regain implies a reversion to starting mass in about one and a half years.

Analyzing Approaches

The study, which reviewed dozens of studies involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with other pills.

Scientists emphasize that individuals who lose weight through diet and exercise generally have a less rapid creep back—approximately 100 grams monthly—once they finish.

Understanding the Fast Rebound

Doctors believe the mechanism of the jabs explains the amplified regain.

These medications copy a natural hormone called GLP-1, which moderates appetite.

"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the body to generate a reduced amount of its endogenous GLP-1, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' leads to appetite is unsuppressed, making overeating much more probable."

A Lifelong Issue?

Health authorities advise the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.

A number of clinicians argue that, given the significant potential of relapse, the therapy might need to be life-long.

This view is echoed by drug manufacturers, who note that the findings "emphasize the long-term character of obesity," similar to managing conditions like diabetes.

User Experiences

Individuals who have stopped the jabs explain a sudden return of cravings.

"It was like a trigger that goes on and you're instantly ravenous," said an individual.

The struggle is exacerbated if patients have not developed permanent lifestyle or habit modifications during therapy.

Growing Adoption

Recent estimates suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.

• Use is greater among women than males.
• The middle-aged age group shows the greatest usage rates.
• A large proportion obtain the medications through private healthcare rather than public health services.

Ultimately, clinicians stress that while GLP-1 drugs are potent agents for shedding pounds, they are not a magic cure and maintained weight loss relies on combined behavioural management.